2,646
Participants
Start Date
February 3, 2022
Primary Completion Date
March 3, 2022
Study Completion Date
March 3, 2023
COVID-19 Vaccine 40 ug/dose
Intramuscular injection of 0,5 ml with 40 ug of recombinant PHH-1V
Hospital Universitari Dr. Josep Trueta, Girona
Hospital Clinic de Barcelona, Barcelona
Hospital de Niguarda, Milan
Hospital Gregorio Marañón, Madrid
Hospital Universitario La Paz, Madrid
Hospital HM Sanchinarro, Madrid
Hospital Quironsalud Madrid, Madrid
Hospital HM Montepríncipe, Madrid
Hospital Principe de Asturias, Meco
Hospital HM Puerta del Sur, Móstoles
Hospital Regional Universitario de Málaga, Málaga
Hospital Clínico de Valencia, Valencia
Hospital de Cruces, Barakaldo
Hospital Germans Trias I Pujol, Badalona
Hospital de Mollet, Mollet del Vallès
Hospital HM Delfos, Barcelona
Hospital Quironsalud Barcelona, Barcelona
Hospital Vall Hebron, Barcelona
Lead Sponsor
Hipra Scientific, S.L.U
INDUSTRY